Stephanie Rist, Minister of Health, Families, Autonomy and Persons with Disabilities, France, shared a post on LinkedIn:
“Yesterday, we launched the INTERCEPTION experiment, a major step to advance the prevention of high-risk cancers in France.
Faced with a clear observation, cancer remains the leading cause of death in our country, we must go further, in particular to better support people at high risk.
With INTERCEPTION, we are choosing a more personalized, more anticipatory and better coordinated medicine.
In concrete terms, this experiment will make it possible to identify high-risk patients earlier thanks to digital technology. Each patient will thus be offered an adapted prevention pathway in close collaboration with the expert centers (evaluation, educational approach, personalized prevention plan), the community professionals and the attending physician.
Deployed in 7 territories and including 6440 patients, this initiative is based on a strong conviction: better prevention means saving lives.
It is also a new way of thinking about our health system, by acting earlier, as close as possible to patients and territories.
We will continue to support innovations that are concrete, useful and at the service of all.
Read the press release.”
Elie Rassy, Senior Clinical Scientist at Gustave Roussy, shared this post, adding:
“Shout‑out to the incredible Interception team at Gustave Roussy.
The one and only Suzette Delaloge, Olivier Caron.
And to the entire clinical team: Pamela Abdayem, Thomas Pudlarz, Lucie Veron, Tarek Ben Ahmed, Brice Fresneau.”
Other articles on OncoDaily.
